[Associations of hemostasis factors genes with early development of ischemic heart disease and manifestation of myocardial infarction in young age]

Kardiologiia. 2005;45(12):17-24.
[Article in Russian]

Abstract

Aim: To study polymorphisms of genes of factors of the system of hemostasis in young patients with ischemic heart disease (IHD).

Material: Two groups of patients participated in the study: patients with first manifestation of IHD at the age < or = 50 years (men) or < or = 55 years (women) (n=158), and patients with first IHD manifestation at the age > or = 70 years (n=92).

Methods: We studied polymorphic markers of genes encoding clotting factors V (F5) and VII (F7), subunit IIIa of platelet integrin (ITGB3), beta-chain of fibrinogen (FGB) and tissue plasminogen activator type 1 (PLANH1).

Results: After separation of a subgroup of patients with MI without preceding angina we revealed significant differences in distribution of frequencies of genotypes of polymorphic marker C(-426)T of factor V gene: genotype TT was significantly more frequent in young (14.9%) than in old (2%) patients (p=0.008). Multifactorial logistic regression revealed independent association of early IHD with smoking (OR 6.112 [2.567-14.552]; p<0.001) and presence of genotype TT of C(-426)T polymorphic marker of F5 gene (OR=9.410 [1.074-82.459]; p=0.043).

Conclusion: Thus we obtained data on the presence of independent association between IHD risk and manifestation of MI in young age with genotype TT of polymorphic marker C(-426)T of F5 gene as well as with traditional risk factors of IHD.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Alleles
  • Blood Coagulation Factors / genetics*
  • Data Interpretation, Statistical
  • Factor V / genetics
  • Factor VII / genetics
  • Female
  • Fibrinogen / genetics
  • Genotype
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Myocardial Infarction / genetics*
  • Myocardial Ischemia / genetics*
  • Polymorphism, Genetic*
  • Risk Factors
  • Smoking / adverse effects
  • Tissue Plasminogen Activator / genetics

Substances

  • Blood Coagulation Factors
  • Factor V
  • Factor VII
  • Fibrinogen
  • Tissue Plasminogen Activator